![DiaSorin S.p.A. Stock Forecast: down to 62.803 EUR? - DIA Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis DiaSorin S.p.A. Stock Forecast: down to 62.803 EUR? - DIA Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis](https://walletinvestorstorage.b-cdn.net/forecast-graphs/2d/stock-dia-stock-forecast-short.png?v=1694888413)
DiaSorin S.p.A. Stock Forecast: down to 62.803 EUR? - DIA Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
![Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2021-04-22/SDD-2734C.jpg)
Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com
![DiaSorin S.p.A.: Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener DiaSorin S.p.A.: Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener](https://www.marketscreener.com/static/address/410424.png)
DiaSorin S.p.A.: Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener
![DiaSorin Showcases Latest Assays and Reagents for In-Vitro Diagnostics - EUROMEDLAB 2023 - mobile.Labmedica.com DiaSorin Showcases Latest Assays and Reagents for In-Vitro Diagnostics - EUROMEDLAB 2023 - mobile.Labmedica.com](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2023-05-22/SDD-294797265.jpg)
DiaSorin Showcases Latest Assays and Reagents for In-Vitro Diagnostics - EUROMEDLAB 2023 - mobile.Labmedica.com
DiaSorin, Consob sanction of EUR100,000; suspended Ad Rosa -June 06, 2023 at 02:32 am EDT | MarketScreener
![Diasorin scivola dopo il piano al 2025. Akros sospende il giudizio in attesa dell'Investor Day - MilanoFinanza News Diasorin scivola dopo il piano al 2025. Akros sospende il giudizio in attesa dell'Investor Day - MilanoFinanza News](https://www.milanofinanza.it/remote/static.milanofinanza.it/content_upload/img/2021/12/202112170736171385/diasorin-646132.jpg)
Diasorin scivola dopo il piano al 2025. Akros sospende il giudizio in attesa dell'Investor Day - MilanoFinanza News
![Azioni, Diasorin in borsa ha più che dimezzato il suo valore dai fasti del Covid. Ecco il piano per la (difficile) ripartenza - MilanoFinanza News Azioni, Diasorin in borsa ha più che dimezzato il suo valore dai fasti del Covid. Ecco il piano per la (difficile) ripartenza - MilanoFinanza News](https://www.milanofinanza.it/remote/static.milanofinanza.it/content_upload/img/2023/12/202312230836083105/Imagoeconomica_1747254-154325.jpg?w=403&h=226&mode=crop&anchor=topcenter&format=jpg&quality=75)